Evidence map›Paper›PMID 41279710›Full record

ArticlebioRxiv : the preprint server for biology2025

Bacteriophage-mediated reduction of uropathogenic

Bishnu Joshi, Jacob J Zulk, Camille Serchejian, Zainab A Hameed, Addison B Larson, Austen L Terwilliger, Deepak Kumar, Indira U Mysorekar, Robert A Britton, Anthony W Maresso and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Bishnu JoshiDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.
Jacob J ZulkDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.
Camille SerchejianDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.
Zainab A HameedDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.
Addison B LarsonDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.
Austen L TerwilligerDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.
Deepak KumarDepartment of Medicine, Section of Infectious Diseases, Baylor College of Medicine.
Indira U MysorekarDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.ORCID 0000-0003-4539-9257
Robert A BrittonDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.ORCID 0000-0001-8983-9539
Anthony W MaressoDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.
Kathryn A PatrasDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, 77030.ORCID 0000-0003-2631-8810

Funding

Organoid Cultivation CoreU19AI157981 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI LEMON, KATHERINE PAIGE · 2021 to 2025
$12.4M
Investigating phage therapy for the treatment of urinary tract infectionsF31DK136201 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI ZULK, JACOB JEFFREY · 2023 to 2024
$97k
NIAID NIH HHS U19 AI157981NIDDK NIH HHS F31 DK136201
6 · The paper itself

Abstract

Urinary tract infections (UTIs), primarily caused by uropathogenic

Indexed as

bacteriophage therapyUrinary tract infectionuropathogenic E. colivaginal colonization

Identifiers

PMID41279710
PMCPMC12632300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.